Article
Circulating Tumor DNA as a Liquid Biopsy for Cancer
12 Nov 2014
Abstract excerpt
BACKGROUND: Targeted therapies have markedly changed the treatment of cancer over the past 10 years. However, almost all tumors acquire resistance to systemic treatment as a result of tumor heterogeneity, clonal evolution, and selection. Although genotyping is the most currently used method for categorizing tumors for clinical decisions, tumor tissues provide only a snapshot, or are often difficult to obtain. To...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
